Malaria, the Killer

News Release 23-Apr-2021 / University of Oxford https://www.eurekalert.org/pub_releases/2021-04/uoo-mvb042221.php Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up. When I arrived in…Read more »